1-11 of 11
Mark Kelley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1410: PI3K inhibitors reduce breast cancer tumor growth and enhance anti-tumor leukocyte activity

Nicole Lavender, Jinming Yang, Jiqing Sai, Sergey Novitskiy, Linda Horton, Andrew Johnson, Vandana Abramson, Ingrid Mayer, Ingrid Meszoely, Mark Kelley, Ann Richmond
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1410.
https://doi.org/10.1158/1538-7445.AM2016-1410
Published: 15 July 2016
View article titled, Abstract 1410: PI3K inhibitors reduce breast cancer tumor growth and enhance anti-tumor leukocyte activity
Journal Articles

Abstract PD6-3: Recurrent ESR1 fusion transcripts are associated with endocrine resistance in estrogen receptor positive, HER2 negative breast cancer

Jennifer M Giltnane, Justin M Balko, Thomas L Stricker, Christian Young, M Valeria Estrada, Nikhil Wagle, Eliezer van Allen, X Jasmine Mu, Violeta Sanchez, Jaime Farley, Kerry Fitzgerald, Armin Graber, Joseph A Pinto, Franco Doimi, Henry Gómez, Monica Rizzo, Thomas B Julian, Vandana Abramson, Ingrid Mayer, Mark Kelley, Ashwini Yenamandra, Ferrin C Wheeler, Melinda Sanders, Levi Garraway, Ingrid Meszoely, Carlos L Arteaga
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD6-3.
https://doi.org/10.1158/1538-7445.SABCS14-PD6-3
Published: 01 May 2015
View article titled, Abstract PD6-3: Recurrent ESR1 fusion transcripts are associated with endocrine resistance in estrogen receptor positive, HER2 negative breast cancer
Journal Articles

Abstract 2616: Association of UGT2B17 gene copy number variation with breast cancer risk: The Nashville Breast Health Study

Guoliang Li, Sandra L. Deming, Qiuyin Cai, Alecia M. Fair, Martha J. Shrubsole, Xiao Ou Shu, Mark Kelley, Wei Zheng
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2616.
https://doi.org/10.1158/1538-7445.AM2012-2616
Published: 15 April 2012
View article titled, Abstract 2616: Association of <em>UGT2B17</em> gene copy number variation with breast cancer risk: The Nashville Breast Health Study
Journal Articles

Abstract #4817: Breast cancer risk factors among Caucasian-American and African-American women

Yong Cui, Sandra Deming, Alecia Fair, Martha Shrubsole, Jianguo Liu, Mark Kelley, Xiao-Ou Shu, Wei Zheng
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4817.
Published: 01 May 2009
View article titled, Abstract #4817: Breast cancer risk factors among Caucasian-American and African-American women
Journal Articles

Abstract #454: Sensitization of pancreatic cancer cells via inhibition of Ape1, a DNA base excision repair enzyme and redox signaling protein

Melissa Fishel, Yanlin Jiang, Ying He, Mark Kelley
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 454.
Published: 01 May 2009
View article titled, Abstract #454: Sensitization of pancreatic cancer cells via inhibition of Ape1, a DNA base excision repair enzyme and redox signaling protein
Journal Articles

Abstract #133: Inhibition of APE1/Ref-1 redox function as an anti-angiogenic molecular target

Melissa Fishel, April Reed, Meihua Luo, Mark Kelley
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 133.
Published: 01 May 2009
View article titled, Abstract #133: Inhibition of APE1/Ref-1 redox function as an anti-angiogenic molecular target
Journal Articles

High resolution epigenomic analysis of melanoma reveals that combination of aberrant DNA methylation and gene copy number alterations can contribute to oncogenesis.

Yongkai Mo, Kathy Amiri, Mark Kelley, Davendra Sohal, Li Zhou, Tushar Bhagat, Perry Pahanish, Maria Figueroa, Kenny Ye, Reid Thomas, Ari Melnick, John Greally, Jeffrey Sosman, Amit Verma
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-251.
Published: 01 May 2008
View article titled, High resolution epigenomic analysis of melanoma reveals that combination of aberrant DNA methylation and gene copy number alterations can contribute to oncogenesis.
Journal Articles

Inhibition of Ape1's DNA repair activity as a target in cancer

Aditi Bapat, Melissa Fishel, Millie Georgiadis, LaTeca Glass, Mark Kelley
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5775.
Published: 01 May 2008
View article titled, Inhibition of Ape1's DNA repair activity as a target in cancer
Journal Articles

t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism

Abbes Belkhiri, Altaf A. Dar, Alexander Zaika, Mark Kelley, Wael El-Rifai
Journal: Cancer Research
Cancer Res (2008) 68 (2): 395–403.
https://doi.org/10.1158/0008-5472.CAN-07-1580
Published: 15 January 2008
View article titled, t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism
Open the PDF for t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism in another window
Journal Articles

Role of the DNA repair and redox enzyme Ape1/Ref-1 in neurotoxicity of cisplatin on dorsal root ganglion neurons: Implications for peripheral neuropathy

Yanlin Jiang, Chunlu Guo, Michael Vasko, Mark Kelley
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1973.
Published: 01 May 2007
View article titled, Role of the DNA repair and redox enzyme Ape1/Ref-1 in neurotoxicity of cisplatin on dorsal root ganglion neurons: Implications for peripheral neuropathy
Journal Articles

Phase I trial of bortezomib (VELADE®), a proteasome inhibitor, in combination with Temozolomide (TMZ) in advanced melanoma: pharmacodynamics in blood and tumor tissue.

Jeffrey A. Sosman, Yu Singjun, Mark Kelley, Linda Horton, Ken Wyman, Victoria Paty, Kathy Amiri, Ann Richmond
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 107–108.
Published: 01 May 2005
View article titled, Phase I trial of bortezomib (VELADE®), a proteasome inhibitor, in combination with Temozolomide (TMZ) in advanced melanoma: <em>pharmacodynamics in blood and tumor tissue</em>.